 | • レポートコード：MRC2-11QY11638 • 出版社/出版日：QYResearch / 2020年11月25日 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、125ページ • 納品方法：Eメール（納期：2~3日） • 産業分類：ヘルスケア |
| Single User | ￥585,000 (USD3,900) | ▷ お問い合わせ |
| Multi User | ￥877,500 (USD5,850) | ▷ お問い合わせ |
| Enterprise License | ￥1,170,000 (USD7,800) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 当調査資料は糖尿病網膜症（DR）治療のグローバル市場について調査・分析したレポートです。種類別（増殖性糖尿病性網膜症（PDR）、非増殖性糖尿病性網膜症（NPDR））市場規模、用途別（眼科クリニック、外来手術センター、病院、その他）市場規模、地域別（北米、米国、カナダ、ヨーロッパ、ドイツ、フランス、イギリス、イタリア、ロシア、アジア、日本、中国、韓国、インド、オーストラリア、台湾、中南米、メキシコ、ブラジル、アルゼンチン、中東・アフリカ、トルコ、サウジアラビア、UAE等）市場規模データ、主な企業情報と企業別市場シェア等が収録されています。 ・調査範囲 ・エグゼクティブサマリー ・企業別糖尿病網膜症（DR）治療の競争状況、市場シェア ・世界の糖尿病網膜症（DR）治療市場：種類別市場規模 2015年-2020年（増殖性糖尿病性網膜症（PDR）、非増殖性糖尿病性網膜症（NPDR）） ・世界の糖尿病網膜症（DR）治療市場：種類別市場規模予測 2021年-2026年（増殖性糖尿病性網膜症（PDR）、非増殖性糖尿病性網膜症（NPDR）） ・世界の糖尿病網膜症（DR）治療市場：用途別市場規模 2015年-2020年（眼科クリニック、外来手術センター、病院、その他） ・世界の糖尿病網膜症（DR）治療市場：用途別市場規模予測 2021年-2026年（眼科クリニック、外来手術センター、病院、その他） ・北米の糖尿病網膜症（DR）治療市場分析：米国、カナダ ・ヨーロッパの糖尿病網膜症（DR）治療市場分析：ドイツ、フランス、イギリス、イタリア、ロシア等 ・アジアの糖尿病網膜症（DR）治療市場分析：日本、中国、韓国、インド、オーストラリア、台湾等 ・中南米の糖尿病網膜症（DR）治療市場分析：メキシコ、ブラジル、アルゼンチン等 ・中東・アフリカの糖尿病網膜症（DR）治療市場分析：トルコ、サウジアラビア、UAE等 ・企業情報（企業概要、製品概要、販売量、企業動向） - 掲載企業（変更可能性あり）：Regeneron Pharmaceuticals、ThromboGenics、Genentech、Bayer Healthcare、Alimera Sciences、Actavis、BCN Peptides、Novartis、Ampio Pharmaceuticals、Kowa Group、Sirnaomicsorporation、Abbott Laboratories、Glycadia Pharmaceuticals、Alcon Laboratories、Parexel International ・地域別市場規模予測（2021年-2026年）：北米市場、ヨーロッパ市場、アジア市場、中南米市場、中東・アフリカ市場 ・市場機会、課題、リスク、環境分析 ・バリューチェーン、販売チャネル分析 ・調査の結論 |
Diabetic retinopathy (die-uh-BET-ik ret-ih-NOP-uh-thee) is a diabetes complication that affects eyes. It’s caused by damage to the blood vessels of the light-sensitive tissue at the back of the eye (retina).
Market Analysis and Insights: Global Diabetic Retinopathy Treatment Market
The global Diabetic Retinopathy Treatment market size is projected to reach US$ XX million by 2026, from US$ XX million in 2020, at a CAGR of XX%% during 2021-2026.
Global Diabetic Retinopathy Treatment Scope and Market Size
Diabetic Retinopathy Treatment market is segmented by Type, and by Application. Players, stakeholders, and other participants in the global Diabetic Retinopathy Treatment market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2015-2026.
The key players covered in this study
Regeneron Pharmaceuticals
ThromboGenics
Genentech
Bayer Healthcare
Alimera Sciences
Actavis
BCN Peptides
Novartis
Ampio Pharmaceuticals
Kowa Group
Sirnaomicsorporation
Abbott Laboratories
Glycadia Pharmaceuticals
Alcon Laboratories
Parexel International
Market segment by Type, the product can be split into
Proliferative Diabetic Retinopathy (PDR)
Non-Proliferative Diabetic Retinopathy (NPDR)
Market segment by Application, split into
Ophthalmic Clinics
Ambulatory Surgical Centers
Hospitals
Other End Users
Market segment by Regions/Countries, this report covers
North America
Europe
China
Japan
Southeast Asia
India
1 Report Overview
1.1 Study Scope
1.2 Key Market Segments
1.3 Players Covered: Ranking by Diabetic Retinopathy Treatment Revenue
1.4 Market by Type
1.4.1 Global Diabetic Retinopathy Treatment Market Size Growth Rate by Type: 2020 VS 2026
1.4.2 Proliferative Diabetic Retinopathy (PDR)
1.4.3 Non-Proliferative Diabetic Retinopathy (NPDR)
1.5 Market by Application
1.5.1 Global Diabetic Retinopathy Treatment Market Share by Application: 2020 VS 2026
1.5.2 Ophthalmic Clinics
1.5.3 Ambulatory Surgical Centers
1.5.4 Hospitals
1.5.5 Other End Users
1.6 Study Objectives
1.7 Years Considered
2 Global Growth Trends
2.1 Global Diabetic Retinopathy Treatment Market Perspective (2015-2026)
2.2 Global Diabetic Retinopathy Treatment Growth Trends by Regions
2.2.1 Diabetic Retinopathy Treatment Market Size by Regions: 2015 VS 2020 VS 2026
2.2.2 Diabetic Retinopathy Treatment Historic Market Share by Regions (2015-2020)
2.2.3 Diabetic Retinopathy Treatment Forecasted Market Size by Regions (2021-2026)
2.3 Industry Trends and Growth Strategy
2.3.1 Market Top Trends
2.3.2 Market Drivers
2.3.3 Market Challenges
2.3.4 Porter’s Five Forces Analysis
2.3.5 Diabetic Retinopathy Treatment Market Growth Strategy
2.3.6 Primary Interviews with Key Diabetic Retinopathy Treatment Players (Opinion Leaders)
3 Competition Landscape by Key Players
3.1 Global Top Diabetic Retinopathy Treatment Players by Market Size
3.1.1 Global Top Diabetic Retinopathy Treatment Players by Revenue (2015-2020)
3.1.2 Global Diabetic Retinopathy Treatment Revenue Market Share by Players (2015-2020)
3.1.3 Global Diabetic Retinopathy Treatment Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.2 Global Diabetic Retinopathy Treatment Market Concentration Ratio
3.2.1 Global Diabetic Retinopathy Treatment Market Concentration Ratio (CR5 and HHI)
3.2.2 Global Top 10 and Top 5 Companies by Diabetic Retinopathy Treatment Revenue in 2019
3.3 Diabetic Retinopathy Treatment Key Players Head office and Area Served
3.4 Key Players Diabetic Retinopathy Treatment Product Solution and Service
3.5 Date of Enter into Diabetic Retinopathy Treatment Market
3.6 Mergers & Acquisitions, Expansion Plans
4 Market Size by Type (2015-2026)
4.1 Global Diabetic Retinopathy Treatment Historic Market Size by Type (2015-2020)
4.2 Global Diabetic Retinopathy Treatment Forecasted Market Size by Type (2021-2026)
5 Market Size by Application (2015-2026)
5.1 Global Diabetic Retinopathy Treatment Market Size by Application (2015-2020)
5.2 Global Diabetic Retinopathy Treatment Forecasted Market Size by Application (2021-2026)
6 North America
6.1 North America Diabetic Retinopathy Treatment Market Size (2015-2020)
6.2 Diabetic Retinopathy Treatment Key Players in North America (2019-2020)
6.3 North America Diabetic Retinopathy Treatment Market Size by Type (2015-2020)
6.4 North America Diabetic Retinopathy Treatment Market Size by Application (2015-2020)
7 Europe
7.1 Europe Diabetic Retinopathy Treatment Market Size (2015-2020)
7.2 Diabetic Retinopathy Treatment Key Players in Europe (2019-2020)
7.3 Europe Diabetic Retinopathy Treatment Market Size by Type (2015-2020)
7.4 Europe Diabetic Retinopathy Treatment Market Size by Application (2015-2020)
8 China
8.1 China Diabetic Retinopathy Treatment Market Size (2015-2020)
8.2 Diabetic Retinopathy Treatment Key Players in China (2019-2020)
8.3 China Diabetic Retinopathy Treatment Market Size by Type (2015-2020)
8.4 China Diabetic Retinopathy Treatment Market Size by Application (2015-2020)
9 Japan
9.1 Japan Diabetic Retinopathy Treatment Market Size (2015-2020)
9.2 Diabetic Retinopathy Treatment Key Players in Japan (2019-2020)
9.3 Japan Diabetic Retinopathy Treatment Market Size by Type (2015-2020)
9.4 Japan Diabetic Retinopathy Treatment Market Size by Application (2015-2020)
10 Southeast Asia
10.1 Southeast Asia Diabetic Retinopathy Treatment Market Size (2015-2020)
10.2 Diabetic Retinopathy Treatment Key Players in Southeast Asia (2019-2020)
10.3 Southeast Asia Diabetic Retinopathy Treatment Market Size by Type (2015-2020)
10.4 Southeast Asia Diabetic Retinopathy Treatment Market Size by Application (2015-2020)
11 India
11.1 India Diabetic Retinopathy Treatment Market Size (2015-2020)
11.2 Diabetic Retinopathy Treatment Key Players in India (2019-2020)
11.3 India Diabetic Retinopathy Treatment Market Size by Type (2015-2020)
11.4 India Diabetic Retinopathy Treatment Market Size by Application (2015-2020)
12 Central & South America
12.1 Central & South America Diabetic Retinopathy Treatment Market Size (2015-2020)
12.2 Diabetic Retinopathy Treatment Key Players in Central & South America (2019-2020)
12.3 Central & South America Diabetic Retinopathy Treatment Market Size by Type (2015-2020)
12.4 Central & South America Diabetic Retinopathy Treatment Market Size by Application (2015-2020)
13 Key Players Profiles
13.1 Regeneron Pharmaceuticals
13.1.1 Regeneron Pharmaceuticals Company Details
13.1.2 Regeneron Pharmaceuticals Business Overview
13.1.3 Regeneron Pharmaceuticals Diabetic Retinopathy Treatment Introduction
13.1.4 Regeneron Pharmaceuticals Revenue in Diabetic Retinopathy Treatment Business (2015-2020))
13.1.5 Regeneron Pharmaceuticals Recent Development
13.2 ThromboGenics
13.2.1 ThromboGenics Company Details
13.2.2 ThromboGenics Business Overview
13.2.3 ThromboGenics Diabetic Retinopathy Treatment Introduction
13.2.4 ThromboGenics Revenue in Diabetic Retinopathy Treatment Business (2015-2020)
13.2.5 ThromboGenics Recent Development
13.3 Genentech
13.3.1 Genentech Company Details
13.3.2 Genentech Business Overview
13.3.3 Genentech Diabetic Retinopathy Treatment Introduction
13.3.4 Genentech Revenue in Diabetic Retinopathy Treatment Business (2015-2020)
13.3.5 Genentech Recent Development
13.4 Bayer Healthcare
13.4.1 Bayer Healthcare Company Details
13.4.2 Bayer Healthcare Business Overview
13.4.3 Bayer Healthcare Diabetic Retinopathy Treatment Introduction
13.4.4 Bayer Healthcare Revenue in Diabetic Retinopathy Treatment Business (2015-2020)
13.4.5 Bayer Healthcare Recent Development
13.5 Alimera Sciences
13.5.1 Alimera Sciences Company Details
13.5.2 Alimera Sciences Business Overview
13.5.3 Alimera Sciences Diabetic Retinopathy Treatment Introduction
13.5.4 Alimera Sciences Revenue in Diabetic Retinopathy Treatment Business (2015-2020)
13.5.5 Alimera Sciences Recent Development
13.6 Actavis
13.6.1 Actavis Company Details
13.6.2 Actavis Business Overview
13.6.3 Actavis Diabetic Retinopathy Treatment Introduction
13.6.4 Actavis Revenue in Diabetic Retinopathy Treatment Business (2015-2020)
13.6.5 Actavis Recent Development
13.7 BCN Peptides
13.7.1 BCN Peptides Company Details
13.7.2 BCN Peptides Business Overview
13.7.3 BCN Peptides Diabetic Retinopathy Treatment Introduction
13.7.4 BCN Peptides Revenue in Diabetic Retinopathy Treatment Business (2015-2020)
13.7.5 BCN Peptides Recent Development
13.8 Novartis
13.8.1 Novartis Company Details
13.8.2 Novartis Business Overview
13.8.3 Novartis Diabetic Retinopathy Treatment Introduction
13.8.4 Novartis Revenue in Diabetic Retinopathy Treatment Business (2015-2020)
13.8.5 Novartis Recent Development
13.9 Ampio Pharmaceuticals
13.9.1 Ampio Pharmaceuticals Company Details
13.9.2 Ampio Pharmaceuticals Business Overview
13.9.3 Ampio Pharmaceuticals Diabetic Retinopathy Treatment Introduction
13.9.4 Ampio Pharmaceuticals Revenue in Diabetic Retinopathy Treatment Business (2015-2020)
13.9.5 Ampio Pharmaceuticals Recent Development
13.10 Kowa Group
13.10.1 Kowa Group Company Details
13.10.2 Kowa Group Business Overview
13.10.3 Kowa Group Diabetic Retinopathy Treatment Introduction
13.10.4 Kowa Group Revenue in Diabetic Retinopathy Treatment Business (2015-2020)
13.10.5 Kowa Group Recent Development
13.11 Sirnaomicsorporation
10.11.1 Sirnaomicsorporation Company Details
10.11.2 Sirnaomicsorporation Business Overview
10.11.3 Sirnaomicsorporation Diabetic Retinopathy Treatment Introduction
10.11.4 Sirnaomicsorporation Revenue in Diabetic Retinopathy Treatment Business (2015-2020)
10.11.5 Sirnaomicsorporation Recent Development
13.12 Abbott Laboratories
10.12.1 Abbott Laboratories Company Details
10.12.2 Abbott Laboratories Business Overview
10.12.3 Abbott Laboratories Diabetic Retinopathy Treatment Introduction
10.12.4 Abbott Laboratories Revenue in Diabetic Retinopathy Treatment Business (2015-2020)
10.12.5 Abbott Laboratories Recent Development
13.13 Glycadia Pharmaceuticals
10.13.1 Glycadia Pharmaceuticals Company Details
10.13.2 Glycadia Pharmaceuticals Business Overview
10.13.3 Glycadia Pharmaceuticals Diabetic Retinopathy Treatment Introduction
10.13.4 Glycadia Pharmaceuticals Revenue in Diabetic Retinopathy Treatment Business (2015-2020)
10.13.5 Glycadia Pharmaceuticals Recent Development
13.14 Alcon Laboratories
10.14.1 Alcon Laboratories Company Details
10.14.2 Alcon Laboratories Business Overview
10.14.3 Alcon Laboratories Diabetic Retinopathy Treatment Introduction
10.14.4 Alcon Laboratories Revenue in Diabetic Retinopathy Treatment Business (2015-2020)
10.14.5 Alcon Laboratories Recent Development
13.15 Parexel International
10.15.1 Parexel International Company Details
10.15.2 Parexel International Business Overview
10.15.3 Parexel International Diabetic Retinopathy Treatment Introduction
10.15.4 Parexel International Revenue in Diabetic Retinopathy Treatment Business (2015-2020)
10.15.5 Parexel International Recent Development
14 Analyst’s Viewpoints/Conclusions
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Disclaimer
15.3 Author Details
Table 1. Diabetic Retinopathy Treatment Key Market Segments
Table 2. Key Players Covered: Ranking by Diabetic Retinopathy Treatment Revenue
Table 3. Ranking of Global Top Diabetic Retinopathy Treatment Manufacturers by Revenue (US$ Million) in 2019
Table 4. Global Diabetic Retinopathy Treatment Market Size Growth Rate by Type (US$ Million): 2020 VS 2026
Table 5. Key Players of Proliferative Diabetic Retinopathy (PDR)
Table 6. Key Players of Non-Proliferative Diabetic Retinopathy (NPDR)
Table 7. Global Diabetic Retinopathy Treatment Market Size Growth by Application (US$ Million): 2020 VS 2026
Table 8. Global Diabetic Retinopathy Treatment Market Size by Regions (US$ Million): 2020 VS 2026
Table 9. Global Diabetic Retinopathy Treatment Market Size by Regions (2015-2020) (US$ Million)
Table 10. Global Diabetic Retinopathy Treatment Market Share by Regions (2015-2020)
Table 11. Global Diabetic Retinopathy Treatment Forecasted Market Size by Regions (2021-2026) (US$ Million)
Table 12. Global Diabetic Retinopathy Treatment Market Share by Regions (2021-2026)
Table 13. Market Top Trends
Table 14. Key Drivers: Impact Analysis
Table 15. Key Challenges
Table 16. Diabetic Retinopathy Treatment Market Growth Strategy
Table 17. Main Points Interviewed from Key Diabetic Retinopathy Treatment Players
Table 18. Global Diabetic Retinopathy Treatment Revenue by Players (2015-2020) (Million US$)
Table 19. Global Diabetic Retinopathy Treatment Market Share by Players (2015-2020)
Table 20. Global Top Diabetic Retinopathy Treatment Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Diabetic Retinopathy Treatment as of 2019)
Table 21. Global Diabetic Retinopathy Treatment by Players Market Concentration Ratio (CR5 and HHI)
Table 22. Key Players Headquarters and Area Served
Table 23. Key Players Diabetic Retinopathy Treatment Product Solution and Service
Table 24. Date of Enter into Diabetic Retinopathy Treatment Market
Table 25. Mergers & Acquisitions, Expansion Plans
Table 26. Global Diabetic Retinopathy Treatment Market Size by Type (2015-2020) (Million US$)
Table 27. Global Diabetic Retinopathy Treatment Market Size Share by Type (2015-2020)
Table 28. Global Diabetic Retinopathy Treatment Revenue Market Share by Type (2021-2026)
Table 29. Global Diabetic Retinopathy Treatment Market Size Share by Application (2015-2020)
Table 30. Global Diabetic Retinopathy Treatment Market Size by Application (2015-2020) (Million US$)
Table 31. Global Diabetic Retinopathy Treatment Market Size Share by Application (2021-2026)
Table 32. North America Key Players Diabetic Retinopathy Treatment Revenue (2019-2020) (Million US$)
Table 33. North America Key Players Diabetic Retinopathy Treatment Market Share (2019-2020)
Table 34. North America Diabetic Retinopathy Treatment Market Size by Type (2015-2020) (Million US$)
Table 35. North America Diabetic Retinopathy Treatment Market Share by Type (2015-2020)
Table 36. North America Diabetic Retinopathy Treatment Market Size by Application (2015-2020) (Million US$)
Table 37. North America Diabetic Retinopathy Treatment Market Share by Application (2015-2020)
Table 38. Europe Key Players Diabetic Retinopathy Treatment Revenue (2019-2020) (Million US$)
Table 39. Europe Key Players Diabetic Retinopathy Treatment Market Share (2019-2020)
Table 40. Europe Diabetic Retinopathy Treatment Market Size by Type (2015-2020) (Million US$)
Table 41. Europe Diabetic Retinopathy Treatment Market Share by Type (2015-2020)
Table 42. Europe Diabetic Retinopathy Treatment Market Size by Application (2015-2020) (Million US$)
Table 43. Europe Diabetic Retinopathy Treatment Market Share by Application (2015-2020)
Table 44. China Key Players Diabetic Retinopathy Treatment Revenue (2019-2020) (Million US$)
Table 45. China Key Players Diabetic Retinopathy Treatment Market Share (2019-2020)
Table 46. China Diabetic Retinopathy Treatment Market Size by Type (2015-2020) (Million US$)
Table 47. China Diabetic Retinopathy Treatment Market Share by Type (2015-2020)
Table 48. China Diabetic Retinopathy Treatment Market Size by Application (2015-2020) (Million US$)
Table 49. China Diabetic Retinopathy Treatment Market Share by Application (2015-2020)
Table 50. Japan Key Players Diabetic Retinopathy Treatment Revenue (2019-2020) (Million US$)
Table 51. Japan Key Players Diabetic Retinopathy Treatment Market Share (2019-2020)
Table 52. Japan Diabetic Retinopathy Treatment Market Size by Type (2015-2020) (Million US$)
Table 53. Japan Diabetic Retinopathy Treatment Market Share by Type (2015-2020)
Table 54. Japan Diabetic Retinopathy Treatment Market Size by Application (2015-2020) (Million US$)
Table 55. Japan Diabetic Retinopathy Treatment Market Share by Application (2015-2020)
Table 56. Southeast Asia Key Players Diabetic Retinopathy Treatment Revenue (2019-2020) (Million US$)
Table 57. Southeast Asia Key Players Diabetic Retinopathy Treatment Market Share (2019-2020)
Table 58. Southeast Asia Diabetic Retinopathy Treatment Market Size by Type (2015-2020) (Million US$)
Table 59. Southeast Asia Diabetic Retinopathy Treatment Market Share by Type (2015-2020)
Table 60. Southeast Asia Diabetic Retinopathy Treatment Market Size by Application (2015-2020) (Million US$)
Table 61. Southeast Asia Diabetic Retinopathy Treatment Market Share by Application (2015-2020)
Table 62. India Key Players Diabetic Retinopathy Treatment Revenue (2019-2020) (Million US$)
Table 63. India Key Players Diabetic Retinopathy Treatment Market Share (2019-2020)
Table 64. India Diabetic Retinopathy Treatment Market Size by Type (2015-2020) (Million US$)
Table 65. India Diabetic Retinopathy Treatment Market Share by Type (2015-2020)
Table 66. India Diabetic Retinopathy Treatment Market Size by Application (2015-2020) (Million US$)
Table 67. India Diabetic Retinopathy Treatment Market Share by Application (2015-2020)
Table 68. Central & South America Key Players Diabetic Retinopathy Treatment Revenue (2019-2020) (Million US$)
Table 69. Central & South America Key Players Diabetic Retinopathy Treatment Market Share (2019-2020)
Table 70. Central & South America Diabetic Retinopathy Treatment Market Size by Type (2015-2020) (Million US$)
Table 71. Central & South America Diabetic Retinopathy Treatment Market Share by Type (2015-2020)
Table 72. Central & South America Diabetic Retinopathy Treatment Market Size by Application (2015-2020) (Million US$)
Table 73. Central & South America Diabetic Retinopathy Treatment Market Share by Application (2015-2020)
Table 74. Regeneron Pharmaceuticals Company Details
Table 75. Regeneron Pharmaceuticals Business Overview
Table 76. Regeneron Pharmaceuticals Product
Table 77. Regeneron Pharmaceuticals Revenue in Diabetic Retinopathy Treatment Business (2015-2020) (Million US$)
Table 78. Regeneron Pharmaceuticals Recent Development
Table 79. ThromboGenics Company Details
Table 80. ThromboGenics Business Overview
Table 81. ThromboGenics Product
Table 82. ThromboGenics Revenue in Diabetic Retinopathy Treatment Business (2015-2020) (Million US$)
Table 83. ThromboGenics Recent Development
Table 84. Genentech Company Details
Table 85. Genentech Business Overview
Table 86. Genentech Product
Table 87. Genentech Revenue in Diabetic Retinopathy Treatment Business (2015-2020) (Million US$)
Table 88. Genentech Recent Development
Table 89. Bayer Healthcare Company Details
Table 90. Bayer Healthcare Business Overview
Table 91. Bayer Healthcare Product
Table 92. Bayer Healthcare Revenue in Diabetic Retinopathy Treatment Business (2015-2020) (Million US$)
Table 93. Bayer Healthcare Recent Development
Table 94. Alimera Sciences Company Details
Table 95. Alimera Sciences Business Overview
Table 96. Alimera Sciences Product
Table 97. Alimera Sciences Revenue in Diabetic Retinopathy Treatment Business (2015-2020) (Million US$)
Table 98. Alimera Sciences Recent Development
Table 99. Actavis Company Details
Table 100. Actavis Business Overview
Table 101. Actavis Product
Table 102. Actavis Revenue in Diabetic Retinopathy Treatment Business (2015-2020) (Million US$)
Table 103. Actavis Recent Development
Table 104. BCN Peptides Company Details
Table 105. BCN Peptides Business Overview
Table 106. BCN Peptides Product
Table 107. BCN Peptides Revenue in Diabetic Retinopathy Treatment Business (2015-2020) (Million US$)
Table 108. BCN Peptides Recent Development
Table 109. Novartis Business Overview
Table 110. Novartis Product
Table 111. Novartis Company Details
Table 112. Novartis Revenue in Diabetic Retinopathy Treatment Business (2015-2020) (Million US$)
Table 113. Novartis Recent Development
Table 114. Ampio Pharmaceuticals Company Details
Table 115. Ampio Pharmaceuticals Business Overview
Table 116. Ampio Pharmaceuticals Product
Table 117. Ampio Pharmaceuticals Revenue in Diabetic Retinopathy Treatment Business (2015-2020) (Million US$)
Table 118. Ampio Pharmaceuticals Recent Development
Table 119. Kowa Group Company Details
Table 120. Kowa Group Business Overview
Table 121. Kowa Group Product
Table 122. Kowa Group Revenue in Diabetic Retinopathy Treatment Business (2015-2020) (Million US$)
Table 123. Kowa Group Recent Development
Table 124. Sirnaomicsorporation Company Details
Table 125. Sirnaomicsorporation Business Overview
Table 126. Sirnaomicsorporation Product
Table 127. Sirnaomicsorporation Revenue in Diabetic Retinopathy Treatment Business (2015-2020) (Million US$)
Table 128. Sirnaomicsorporation Recent Development
Table 129. Abbott Laboratories Company Details
Table 130. Abbott Laboratories Business Overview
Table 131. Abbott Laboratories Product
Table 132. Abbott Laboratories Revenue in Diabetic Retinopathy Treatment Business (2015-2020) (Million US$)
Table 133. Abbott Laboratories Recent Development
Table 134. Glycadia Pharmaceuticals Company Details
Table 135. Glycadia Pharmaceuticals Business Overview
Table 136. Glycadia Pharmaceuticals Product
Table 137. Glycadia Pharmaceuticals Revenue in Diabetic Retinopathy Treatment Business (2015-2020) (Million US$)
Table 138. Glycadia Pharmaceuticals Recent Development
Table 139. Alcon Laboratories Company Details
Table 140. Alcon Laboratories Business Overview
Table 141. Alcon Laboratories Product
Table 142. Alcon Laboratories Revenue in Diabetic Retinopathy Treatment Business (2015-2020) (Million US$)
Table 143. Alcon Laboratories Recent Development
Table 144. Parexel International Company Details
Table 145. Parexel International Business Overview
Table 146. Parexel International Product
Table 147. Parexel International Revenue in Diabetic Retinopathy Treatment Business (2015-2020) (Million US$)
Table 148. Parexel International Recent Development
Table 149. Research Programs/Design for This Report
Table 150. Key Data Information from Secondary Sources
Table 151. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Diabetic Retinopathy Treatment Market Share by Type: 2020 VS 2026
Figure 2. Proliferative Diabetic Retinopathy (PDR) Features
Figure 3. Non-Proliferative Diabetic Retinopathy (NPDR) Features
Figure 4. Global Diabetic Retinopathy Treatment Market Share by Application: 2020 VS 2026
Figure 5. Ophthalmic Clinics Case Studies
Figure 6. Ambulatory Surgical Centers Case Studies
Figure 7. Hospitals Case Studies
Figure 8. Other End Users Case Studies
Figure 9. Diabetic Retinopathy Treatment Report Years Considered
Figure 10. Global Diabetic Retinopathy Treatment Market Size YoY Growth 2015-2026 (US$ Million)
Figure 11. Global Diabetic Retinopathy Treatment Market Share by Regions: 2020 VS 2026
Figure 12. Global Diabetic Retinopathy Treatment Market Share by Regions (2021-2026)
Figure 13. Porter's Five Forces Analysis
Figure 14. Global Diabetic Retinopathy Treatment Market Share by Players in 2019
Figure 15. Global Top Diabetic Retinopathy Treatment Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Diabetic Retinopathy Treatment as of 2019
Figure 16. The Top 10 and 5 Players Market Share by Diabetic Retinopathy Treatment Revenue in 2019
Figure 17. North America Diabetic Retinopathy Treatment Market Size YoY Growth (2015-2020) (Million US$)
Figure 18. Europe Diabetic Retinopathy Treatment Market Size YoY Growth (2015-2020) (Million US$)
Figure 19. China Diabetic Retinopathy Treatment Market Size YoY Growth (2015-2020) (Million US$)
Figure 20. Japan Diabetic Retinopathy Treatment Market Size YoY Growth (2015-2020) (Million US$)
Figure 21. Southeast Asia Diabetic Retinopathy Treatment Market Size YoY Growth (2015-2020) (Million US$)
Figure 22. India Diabetic Retinopathy Treatment Market Size YoY Growth (2015-2020) (Million US$)
Figure 23. Central & South America Diabetic Retinopathy Treatment Market Size YoY Growth (2015-2020) (Million US$)
Figure 24. Bottom-up and Top-down Approaches for This Report
Figure 25. Data Triangulation
Figure 26. Key Executives Interviewed
増殖性糖尿病性網膜症の世界市場（～2026年） Market Analysis and Insights: Global Proliferative Diabetic Retinopathy Market The global Proliferative Diabetic Retinopathy market size is projected to reach US$ 455.6 million by 2026, from US$ 430.5 million in 2020, at a CAGR of 5.4%% during 2021-2026. Global Proliferative Diabetic Retinopathy Sco…- 増殖性糖尿病性網膜症治療治療薬の世界市場（～2026年） Market Analysis and Insights: Global Proliferative Diabetic Retinopathy Therapeutics Market The global Proliferative Diabetic Retinopathy Therapeutics market size is projected to reach US$ XX million by 2026, from US$ XX million in 2020, at a CAGR of XX%% during 2021-2026. Global Proliferative Diabe…
- 糖尿病網膜症（DR）治療薬の世界市場（～2026年） Diabetic retinopathy is an ophthalmic disorder, in which blindness occurrs due to complications in diabetes. The North American region is the most lucrative market, owing to large number of elderly population in the U.S. However, European and Asia-Pacific regions are considered as the most promising…
- 黄斑変性症（AMD）・糖尿病性網膜症（DR）治療薬の世界市場（～2026年） Age related macular degeneration (AMD) is a medical condition that results in loss of vision in the central visual field, owing to damage to the retina. This is usually an age-related disorder, which affects adults with the age 50 and above. Diabetic retinopathy is an ophthalmic disorder, in which b…
- 糖尿病網膜症（DR）の世界市場（～2026年） Diabetic retinopathy is a disorder of the eye that damages the blood vessels of the retina. The retina is the light-sensitive inner surface of the eye on which images are formed. Long-term diabetes affects the retina as high blood glucose levels can damage the tiny blood vessels in the retina. Diabe…